BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2896331)

  • 1. Bethanechol chloride as a suggested adjunct to prolonged in vivo exposure therapy in the treatment of paruresis.
    Zgourides GD
    Percept Mot Skills; 1988 Feb; 66(1):319-22. PubMed ID: 2896331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-behavioral therapy for paruresis: a case report.
    Jaspers JP
    Psychol Rep; 1998 Aug; 83(1):187-96. PubMed ID: 9775678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of excessive urinary urgency and frequency by retention control training and desensitization; three case studies.
    Espie CA
    Behav Res Ther; 1985; 23(2):205-10. PubMed ID: 2860890
    [No Abstract]   [Full Text] [Related]  

  • 4. Propranolol treatment of paruresis (psychogenic urinary retention): a brief case report.
    Zgourides GD; Warren R
    Percept Mot Skills; 1990 Dec; 71(3 Pt 1):885-6. PubMed ID: 1981391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations on the cystometric and uroflowmetric effects of bethanechol chloride on the human bladder.
    Sonda LP; Gershon C; Diokno AC; Lapides J
    J Urol; 1979 Dec; 122(6):775-7. PubMed ID: 513222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of excessive urinary frequency and urgency by desensitization and progressive retention training.
    Rovetto FM
    J Behav Ther Exp Psychiatry; 1983 Jun; 14(2):155-9. PubMed ID: 6137496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review.
    Finkbeiner AE
    J Urol; 1985 Sep; 134(3):443-9. PubMed ID: 2863391
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of oral and parenteral bethanechol on decompensated bladder.
    Diokno AC; Lapides J
    Urology; 1977 Jul; 10(1):23-4. PubMed ID: 327652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study.
    Barrett DM
    J Urol; 1981 Nov; 126(5):640-2. PubMed ID: 6117662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of anxiolytic and parasympathomimetic agents in the treatment of postoperative urinary retention following anorectal surgery. A prospective, randomized, double-blind study.
    Gottesman L; Milsom JW; Mazier WP
    Dis Colon Rectum; 1989 Oct; 32(10):867-70. PubMed ID: 2571469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the bethanechol supersensitivity test to predict improved voiding after subcutaneous bethanechol administration.
    Wein AJ; Raezer DM; Malloy TR
    J Urol; 1980 Feb; 123(2):202-3. PubMed ID: 7354517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of bethanechol chloride with tricyclic antidepressants.
    Everett HC
    Am J Psychiatry; 1975 Nov; 132(11):1202-4. PubMed ID: 1166898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral bethanechol chloride on the cystometrogram of the normal male adult.
    Wein AJ; Hanno PM; Dixon DO; Raezer DM; Benson GS
    J Urol; 1978 Sep; 120(3):330-1. PubMed ID: 355661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of paruresis with in vivo desensitization: a case report.
    McCracken LM; Larkin KT
    J Behav Ther Exp Psychiatry; 1991 Mar; 22(1):57-62. PubMed ID: 1680884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotherapeutic treatment of socially inhibited urinary response: two case studies.
    Goggins R
    J Am Soc Psychosom Dent Med; 1983; 30(1):21-5. PubMed ID: 6134701
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of vesical malacoplakia with a combination of bethanechol chloride and ascorbic acid].
    Regin JP; Billerey C; Leconte des Floris R; Bittard M
    J Urol (Paris); 1982; 88(8):533-5. PubMed ID: 6131096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bethanechol as treatment for urinary retention induced by a combination of neuroleptics and anticholinergics].
    Seguí Montesinos J; García Parés G; de Pablo Rabassó J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(6):402-5. PubMed ID: 2871697
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of combination of Ea-0643 (bunazosin hydrochloride) and bethanechol chloride in patients with neurogenic bladder].
    Araki T; Nakano S; Sugimura Y; Tochigi H; Kawamura J; Kato T; Tajima K; Chigusa I; Saito K; Morisita H
    Hinyokika Kiyo; 1990 Nov; 36(11):1379-83. PubMed ID: 1981126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Office urodynamics.
    Wein AJ; English WS; Whitmore KE
    Urol Clin North Am; 1988 Nov; 15(4):609-23. PubMed ID: 2903592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obsessive-compulsive disorders--inpatient behavior therapy].
    Winkelmann G; Hohagen F
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():19-22. PubMed ID: 7635390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.